These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 103092)

  • 21. [Significance of tuberculous infection in pediatric practice and borderline conditions in pediatric nephrology].
    Ezerskiĭ RF; Belykh IN; Bozhenov IuA
    Pediatriia; 1986 Aug; (8):58-60. PubMed ID: 3093971
    [No Abstract]   [Full Text] [Related]  

  • 22. The pulmonary tuberculous lesion in North India: a study in medico-legal autopsies. II. Bacteriologic aspects.
    Bhathena D; Mohapatra LN; Mital GS; Ramalingaswami V; Nayak NC
    Am Rev Respir Dis; 1970 Jan; 101(1):18-26. PubMed ID: 4983002
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].
    Golanov VS; Bogdalova VE; Andreev LP; Losin EI; Ushakova AG; Meshcheriakov VG; Bondin SV
    Probl Tuberk; 1991; (12):27-8. PubMed ID: 1803368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [L-phase growth of mycobacteria. 2. Consideration on the survival of tubercle bacillus in caseous lesion (author's transl)].
    Takahashi S
    Kekkaku; 1979 Apr; 54(4):231-5. PubMed ID: 112315
    [No Abstract]   [Full Text] [Related]  

  • 25. The significance of L-forms of mycobacteria in the clinical picture of tuberculosis.
    Dorozhkova IR; Karachiunski MA
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(3):267-9. PubMed ID: 3027865
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination of host susceptibility and virulence of Mycobacterium tuberculosis determines dual role of nitric oxide in the protection and control of inflammation.
    Beisiegel M; Kursar M; Koch M; Loddenkemper C; Kuhlmann S; Zedler U; Stäber M; Hurwitz R; Kaufmann SH
    J Infect Dis; 2009 Apr; 199(8):1222-32. PubMed ID: 19302011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung remodeling in pulmonary tuberculosis.
    Dheda K; Booth H; Huggett JF; Johnson MA; Zumla A; Rook GA
    J Infect Dis; 2005 Oct; 192(7):1201-9. PubMed ID: 16136463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Virulence of Mycobacteria tuberculosis].
    Vishnevskiĭ BI; Narvskaia OV; Vasil'eva SN; Sapozhnikova NV; Mukrousov IV; Otten TF
    Probl Tuberk; 2002; (10):33-6. PubMed ID: 12593167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics of the course of destructive pulmonary tuberculosis with L-forms of mycobacteria in the sputum].
    Golanov VS
    Vrach Delo; 1981 Aug; (8):79-81. PubMed ID: 6791384
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of the L form in the persistence of pathogenic bacteria].
    Prozorovskiĭ SV
    Vestn Akad Med Nauk SSSR; 1985; (3):3-9. PubMed ID: 3922153
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relations between resistance and virulence of mycobacteria].
    Daddi G
    Arch Monaldi; 1972; 27(4):426-35. PubMed ID: 4217599
    [No Abstract]   [Full Text] [Related]  

  • 32. [Isolation of Mycobacterium tuberculosis and its L-forms from caverns and sputum of patients with pulmonary tuberculosis].
    Tsybul'kina IV
    Probl Tuberk; 1979 Nov; (11):64-8. PubMed ID: 119223
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on thiacetazone resistance of tubercle bacilli. II. The relation between virulence in guinea-pigs and thiacetazone sensitivity of tubercle bacilli isolated from previously untreated tuberculous children].
    Osato T; Tsukagoshi K; Shimizu H
    Kekkaku; 1971 Apr; 46(4):83-7. PubMed ID: 4102104
    [No Abstract]   [Full Text] [Related]  

  • 34. [Determination of immunological cellular reactions in pulmonary tuberculosis by phagocytosis of mycobacteria of varying virulence].
    Khmelevskaia GA
    Lab Delo; 1970; 10():601-5. PubMed ID: 4099563
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathomorphological assessment of the therapeutic effect of mycobacteriophages in tuberculosis].
    Zemskova ZS; Dorozhkova IR
    Probl Tuberk; 1991; (11):63-6. PubMed ID: 1775467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dynamics of L-form Mycobacteria excretion in the treatment of patients with newly diagnosed destructive pulmonary tuberculosis].
    Karachunskiĭ MA; Dorozhkova IR; Balta IuE
    Probl Tuberk; 1978 Mar; (3):66-70. PubMed ID: 418400
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical picture and course of chronic destructive pulmonary tuberculosis in patients secreting L forms of the causative agent].
    Karachunskiĭ MA; Dorozhkova IR; Abdullaeva ET
    Probl Tuberk; 1985; (12):13-6. PubMed ID: 3938018
    [No Abstract]   [Full Text] [Related]  

  • 38. Further studies on the effect of lung antibodies on the pathogenesis of tuberculosis.
    Burrell R; Lewis DM
    J Lab Clin Med; 1975 Nov; 86(5):741-5. PubMed ID: 810530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mycobacterium tuberculosis L forms in patients with abacillary lung caverns].
    Berezovskiĭ BA; Golanov VS
    Probl Tuberk; 1981 Jun; (6):22-5. PubMed ID: 6792625
    [No Abstract]   [Full Text] [Related]  

  • 40. [Frequency of isolation of viable tuberculosis bacteria from patients with different forms of lung tuberculosis].
    Iavors'ka GV; Sybirna RI
    Mikrobiol Z; 2002; 64(1):82-6. PubMed ID: 11944351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.